Perle Bioscience's Angel Round

Perle Bioscience raised a round of funding on September 26, 2013.

Perle Bioscience is engaged in development of new pharmaceutical compositions and methods for reversing Type 1 and 2 Diabetes. Perle is setting the stage for usage of a new proprietary peptide therapy…

Articles about Perle Bioscience's Angel Round: